Trial Profile

A clinical trial evaluating VQ-101

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 31 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VQ 101 (Primary)
Indications Parkinson's disease
Focus Adverse reactions; First in man

Most Recent Events

27 Mar 2025 According to Vanqua Bio media release, company will present interim results data from this study at AD/PD™ 2025 International Conference on Alzheimer and Parkinson Diseases and Related Neurological Disorders, taking place in Vienna, Austria on April 1-5.
09 Oct 2024 According to Vanqua Bio media release, company announced positive interim results of this trial.
09 Oct 2024 Interim results published in the Vanqua Bio media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com